期刊文献+

树模型在慢性乙肝与肝硬化和肝癌临床诊断中的应用 被引量:3

Application of tree model in diagnosis of chronic hepatitis B and cirrhosis of liver or hepatoma
下载PDF
导出
摘要 目的:利用决策树模型挖掘常见的临床检验资料信息,进一步提高慢性乙型肝炎及相关疾病的确诊率.方法:将临床收集的102例慢性乙肝患者和80例肝癌及肝硬化患者常见的17种信息和临床检测结果综合分析,利用决策树卡方自动交互探测(CHAID)和分类与回归树(CRT)两种算法构建预测模型,并采用正确预测率和交互印证对其进行风险评估.结果:进入CHAID和CRT两种算法模型的主要变量是年龄和胆红素指标及职业等,两模型预测慢性乙型和肝炎肝硬化及肝癌的总体准确率分别为71.4%和74.2%.结论:决策树模型在数据挖掘,资料再利用方面效果良好. AIM: To collect and analyze the potential information from the clinical data by the decision tree model, and improve the accuracy of chronic viral hepatitis B (CVHB) , cirrhosis of liver(CL) and hepatocellular carcinoma (HCC) diagnosis. METHODS: Tree structure models were built with chisquared automatic interaction detection (CHAID) and classification and regression tree (CRT) algorithms using normal clinical data from 102 CVHB and 80 CL or HCC patients, and same time were evaluated by cross-Validation and Correct Rate of Predicative. RESULTS: In the two types of model, both age and bilirubin were risk factors, the accuracy rate in predicted classification was 71.4% and 74.2% , respectively. CONCLUSION: Decision tree model is a promising method in data mining and re-utilizing.
出处 《第四军医大学学报》 北大核心 2008年第12期1135-1137,共3页 Journal of the Fourth Military Medical University
基金 河北省科技厅资助(05276101D-86)
关键词 肝炎 乙型 决策树 诊断 hepatitis B decision trees diagnosis
  • 相关文献

参考文献9

二级参考文献28

  • 1盖洪鹏.联合检测HA、LN及PCⅢ对肝纤维化诊断的价值分析[J].中国临床医学,2004,11(5):740-741. 被引量:3
  • 2Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1930
  • 3黄日琼.网络环境下医院统计数据挖掘的应用与展望[J].中国医院统计,2006,13(1):66-67. 被引量:19
  • 4印鉴 刘星成 等.专家系统原理与编程[M].机械工业出版社,2000..
  • 5Takahara T,Sollberg S,Muona P,et al.Type IV collagen gene expression in experimental liver fibrosis:quantitation and partial distribution of mRNA and immunodetection of the protein.Liver,1995,15:78-79.
  • 6Giustina G,Fattovich G,Guido M,et al.Serum procollagen type Ⅲ peptide in chronic hepatitis B.Relationship to disease activity and response to interferon-alpha therapy.Int J Clin Lab Res,1996,26:33-36.
  • 7Pontinha N,Pessegueiro H,Barros H.Seram hyaluronan as a marker of liver fibrosis in asymptomatic chronic viral hepatitis B.Scand J Clin Lab Invest,1999,59:343-347.
  • 8Ramadori G,Zohrens G,Manns M,et al.Serum hyaluronate and type Ⅲ procollagen aminoterminal propeptide concentration in chronic liver disease.Relationship to cirrhosis and disease activity.Eur J Clin Invest,1991,21:323-330.
  • 9Gordon SC,Jacobson I,Hezode C,et al.Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-toadvanced liver fibrosis in chronic hepatitis C patients.J Hepatol,2004,41:935-942.
  • 10Myers RP,Tainturier MH,Ratziu V,et al.Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B.J Hepatol,2003,39:222-230.

共引文献14054

同被引文献19

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部